Synjardy XR 25 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 25 mg/1

Synjardy XR 25 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to help manage type 2 diabetes by improving blood sugar control. This medication is suitable for adults and is available in a convenient pack size of 7 tablets per bottle.

Strength

25 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0597-0295-61) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 25 mg/1 is primarily used for the management of type 2 diabetes in adults. It works by combining two active ingredients, empagliflozin and metformin hydrochloride, to help control blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People often ask, 'What is Synjardy XR used for?' and the answer is that it is designed to improve glycemic control in adults with type 2 diabetes.

Side Effects

Common effects of Synjardy XR 25 mg/1 may include symptoms such as nausea, diarrhea, and headache. Some individuals may also experience urinary tract infections or constipation. These effects can vary from person to person, and it is important to consult with a healthcare provider if any of these symptoms persist or worsen.

Precautions & Warnings

Synjardy XR 25 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Synjardy XR 25 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it can increase the risk of side effects.

Frequently Asked Questions

Synjardy XR 25 mg/1 is used to manage type 2 diabetes in adults by improving blood sugar control.

Synjardy XR 25 mg/1 should be taken orally, typically once daily, with food. Follow the specific instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, headache, and urinary tract infections. Consult your healthcare provider if these effects persist.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Synjardy XR 25 mg/1 is designed for adults with type 2 diabetes. It may not be suitable for everyone, so consult your healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.